Stem cell treatment for Parkinson's disease symptoms
Treatments studied
Part of Brain & nervous system clinical trials.
This study tests whether stem cells or their byproducts can improve movement and quality of life in people with Parkinson's disease. It may offer a new way to slow symptom progression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 80 years old.
- You have been diagnosed with Parkinson's disease or parkinsonism.
- Your symptoms are at stage II or III on the Hoehn and Yahr scale (moderate, affecting both sides or balance).
- Your Parkinson's medications have been stable for at least 3 months.
- You have not had cancer treated or active within the last 5 years.
- You do not have severe heart disease, active infections, or a weakened immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new stem cell treatment for Parkinson's disease. It aims to see if the treatment is safe and may help improve symptoms when current medications stop working well.
This trial uses special stem cells (made from skin or blood cells) to replace damaged brain cells in people with Parkinson's. The goal is to see if these cells can improve movement and reduce symptoms.
This trial tests whether implanting your own stem cells (made into dopamine-producing brain cells) can improve Parkinson's motor symptoms. You would need to be a candidate for brain surgery and have a stable medication routine.
This early-stage trial tests a new stem cell treatment called NCR201 for people with Parkinson's. It aims to see if the treatment is safe and might help improve symptoms.
This trial tests a new cell treatment for Parkinson's disease. It involves injecting special cells into the brain to see if they can safely replace damaged cells and improve symptoms. It might help people who have had Parkinson's for several years and still respond well to medication.
This trial tests a new stem cell treatment called NouvNeu001 for people with early-onset Parkinson's disease. The goal is to see if it's safe and if it can help improve movement and daily life.
Hear when a new Parkinsonism or Parkinson's Disease Nos trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.